These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Seminar on care of the newborn. IV. Newborn hematologic problems. Pullen J; Smith R J Miss State Med Assoc; 1970 Oct; 11(10):543-7 passim. PubMed ID: 4196128 [No Abstract] [Full Text] [Related]
4. Clinical uses of human blood fractions. Schiff P Med J Aust; 1973 Jan; 1(1):22-6. PubMed ID: 4686436 [No Abstract] [Full Text] [Related]
5. Uses of blood and of blood components. Med Lett Drugs Ther; 1972 Nov; 14(24):89-92. PubMed ID: 4648571 [No Abstract] [Full Text] [Related]
6. Surgery in haemophilic patients with inhibitors. Rodriguez-Merchan EC Haemophilia; 2004 Sep; 10 Suppl 2():1-2. PubMed ID: 15385039 [No Abstract] [Full Text] [Related]
7. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK]. Duckert F; Müller G; Meili EO Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501 [No Abstract] [Full Text] [Related]
8. [Long-term follow-up of consumption of plasma, blood and antihemophilic globulin in patients with hemophilia]. Pudlák P; Horák J Vnitr Lek; 1968 Jan; 15(1):1-8. PubMed ID: 5720983 [No Abstract] [Full Text] [Related]
9. [Substitution therapy of coagulopathies]. Beeser H; Egli H Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806 [No Abstract] [Full Text] [Related]
10. [Therapeutic effect on hemophilia by AMCHA]. Gebauer D; Heigel K Med Klin; 1969 Feb; 64(9):378-82. PubMed ID: 5305740 [No Abstract] [Full Text] [Related]
11. Regimens of factor VIII administration--continuous infusion vs. bolus. Berntorp E Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of fractures in patients with hemophilia]. Smilowicz M Wiad Lek; 1970 Apr; 23(7):565-9. PubMed ID: 4917156 [No Abstract] [Full Text] [Related]
13. A study of coagulation factor levels in women during labour and in their newborn infants. Nossel HL; Lanzkowsky P; Levy S; Mibashan RS; Hansen JD Thromb Diath Haemorrh; 1966 Jul; 16(1):185-97. PubMed ID: 5989040 [No Abstract] [Full Text] [Related]
14. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility]. Skrzypulec ZA Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158 [No Abstract] [Full Text] [Related]
15. Surgical care of patients with hereditary disorders of blood coagulation. Shulman NR Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180 [No Abstract] [Full Text] [Related]
16. [Pharmacotherapy of hemophilia with the preparation of Lagochilus inebrians BGE]. Akopow IE Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):72-83. PubMed ID: 4104085 [No Abstract] [Full Text] [Related]
17. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography. Sultan Y; Boyeldieu D; Stieltjes N Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717 [TBL] [Abstract][Full Text] [Related]
18. The use of fraction I for oral surgical procedures in patients with classic hemophilia: report of seven cases. Marder VJ; Gamble JW; Shulman NR J Oral Surg; 1966 Nov; 24(6):487-99. PubMed ID: 5296941 [No Abstract] [Full Text] [Related]
19. The use of blood fractions in coagulation disorders. Biggs R Br J Haematol; 1969 Dec; 17(6):604. PubMed ID: 5357747 [No Abstract] [Full Text] [Related]
20. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease. Josephson CD; Abshire TC Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]